This volume is the first book to cover the general topic of targeted cancer therapy. It presents a range of targets such ...
WeiterlesenThis book is intended for workers in the field and clinicians as a useful guide of the state of affairs in this exciting ...
WeiterlesenThis book provides general information on breast cancer management and considers all new methods of diagnosis and therapy. ...
Weiterlesenthe authors comprehensively review the anticancer genes and gene delivery methods currently available for cancer gene therapy, ...
WeiterlesenA diagnosis of cancer provokes myriad responses in patients, chief among them the question: "how long do I have to live?" ...
WeiterlesenThis book is written by experts with clinical expertise on diagnosis, treatment, and follow-up of women with cancer during ...
WeiterlesenMultimodal treatment lies at the heart of the improvement in cancer cure rates. However, the more aggressive the treatment ...
WeiterlesenDespite the development of cancer treatments and the introduction of new treatments other than traditional treatments, the ...
WeiterlesenFollowing an introductory overview, Hyperthermia In Cancer Treatment: A Primer comprehensively describes the biological reasons ...
WeiterlesenThis volume is based on the LENT V NCI-sponsored meeting held in May 2004 and the CURED I conference held in 2006. It addresses ...
WeiterlesenIn Molecular Targeting in Oncology, authors present an overview of the development of targeted therapies for the treatment ...
WeiterlesenThis book gathers authoritative contributions concerning multiscale problems in biomechanics, geomechanics, materials science ...
WeiterlesenThis book reflects on matters of social and ethical concern raised in the daily practices of those working in and around ...
WeiterlesenLymph node (LN) status is the most important prognostic indicator for the clinical outcome of patients in human solid cancer. ...
WeiterlesenIt was not long ago that clinicians would say,“study ed at the 1975 meeting revealed. Among them was the late complications ...
WeiterlesenCancer is known as abnormal growth of cells due to genetic mutations associated with other factors such as smocking, overweight, ...
WeiterlesenThis book lay out the state of development of tomorrow's cancer drugs, directed against growth factors, growth factor receptors ...
WeiterlesenThe last three decades have provided opportunities to explore the potential of treating malignant diseases with antibodies ...
WeiterlesenThis volume will introduce recent discoveries in the field of cancer metabolism since the publication of the first edition ...
WeiterlesenThe transcription factor NF-kB has long been known to play a central role in the immune system by regulating the expression ...
Weiterlesen